GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » Operating Cash Flow per Share

Asensus Surgical (FRA:2TX) Operating Cash Flow per Share : €-0.22 (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical Operating Cash Flow per Share?

Asensus Surgical's operating cash flow per share for the three months ended in Mar. 2024 was €-0.05. Asensus Surgical's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.22.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 46.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 37.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Asensus Surgical's Operating Cash Flow per Share or its related term are showing as below:

FRA:2TX' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -162.9   Med: 12.6   Max: 66.6
Current: 27.1

During the past 13 years, Asensus Surgical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 66.60% per year. The lowest was -162.90% per year. And the median was 12.60% per year.

FRA:2TX's 3-Year OCF Growth Rate is ranked better than
79.85% of 685 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs FRA:2TX: 27.10

Asensus Surgical Operating Cash Flow per Share Historical Data

The historical data trend for Asensus Surgical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Operating Cash Flow per Share Chart

Asensus Surgical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.73 -0.54 -0.16 -0.24 -0.23

Asensus Surgical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.07 -0.06 -0.05 -0.05

Competitive Comparison of Asensus Surgical's Operating Cash Flow per Share

For the Medical Devices subindustry, Asensus Surgical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's Price-to-Operating-Cash-Flow falls into.



Asensus Surgical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Asensus Surgical's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=-58.346/249.685
=-0.23

Asensus Surgical's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )=Cash Flow from Operations (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=-12.887/269.265
=-0.05

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asensus Surgical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical (FRA:2TX) Business Description

Traded in Other Exchanges
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines